# EDGAR Filing Document

**Accession Number:** 0001840161
**File Stem:** 0001213900-23-012581
**Filing Date:** 2023-2
**Character Count:** 55539
**Document Hash:** c34e8d2a2403f1f63dbb1919146cc141
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-012581.hdr.sgml**: 20230217

**ACCESSION NUMBER**: 0001213900-23-012581

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230216

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230217

**DATE AS OF CHANGE**: 20230217

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Forest Road Acquisition Corp. II
- **CENTRAL INDEX KEY:** 0001840161
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40181
- **FILM NUMBER:** 23640199

**BUSINESS ADDRESS:**
- **STREET 1:** 1177 AVENUE OF THE AMERICAS, 5TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
- **BUSINESS PHONE:** 9173103722

**MAIL ADDRESS:**
- **STREET 1:** 1177 AVENUE OF THE AMERICAS, 5TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Forest Road Acquisition Corp. III
- **DATE OF NAME CHANGE:** 20210112

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(D)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of Report (Date of earliest event reported): February 16, 2023**

**Forest Road Acquisition Corp. II**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-40181** | **86-1376005** |
| **(State or other jurisdiction** | **(Commission File Number)** | **(I.R.S. Employer** |
| **of incorporation)** |  | **Identification No.)** |

---

---

| | |
|:---|:---|
| **1177 Avenue of the Americas, 5th Floor**<br> **New York, New York** | **10036** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

**Registrant's telephone number, including area code (917) 310-3722**

**Not Applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| **Units, each consisting of one share of Class A Common Stock and one-fifth of one Redeemable Warrant** | **FRXB.U** | **The New York Stock Exchange** |
| **Class A Common Stock, par value $0.0001 per share** | **FRXB** | **The New York Stock Exchange** |
| **Redeemable Warrants, each exercisable for one share of Class A Common Stock for $11.50 per share** | **FRXB WS** | **The New York Stock Exchange** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01.** **Entry into a Material Definitive Agreement.**

 ****

On February 16, 2023, Forest Road Acquisition Corp. II (the "***Company***") and Forest Road Acquisition Sponsor II LLC (the "***Sponsor***") entered into a non-redemption agreement ("***Non-Redemption Agreement***") with one or more unaffiliated third party or parties in exchange for such third party or third parties agreeing not to redeem an aggregate of 1,000,000 shares of the Company's Class A common stock sold in its initial public offering ("***Non-Redeemed Shares***") in connection with the special meeting of the stockholders called by the Company (the "***Special Meeting***") to consider and approve an extension of time for the Company to consummate an initial business combination (the "***Extension Proposal***") from March 12, 2023 to December 12, 2023 (the "***Extension***"). In exchange for the foregoing commitments not to redeem such Non-Redeemed Shares, the Sponsor has agreed to transfer to such third party or third parties an aggregate of 250,000 shares of the Company's Class B common stock held by the Sponsor immediately following the consummation of an initial business combination if they continue to hold such Non-Redeemed Shares through the Special Meeting. The Sponsor intends to enter into additional Non-Redemption Agreements prior to the Special Meeting.

In addition, the Company has agreed that, to mitigate the current uncertainty surrounding the implementation of the Inflation Reduction Act of 2022, funds held in the Company's trust account, including any interest thereon, will not be used to pay for any excise tax liabilities with respect to any future redemptions prior to or in connection with the Extension, an initial business combination or the liquidation of the Company.

 

The Non-Redemption Agreements are not expected to increase the likelihood that the Extension Proposal is approved by Company's stockholders but are expected to increase the amount of funds that remain in the Company's trust account following the Special Meeting.

The foregoing summary of the Non-Redemption Agreement does not purport to be complete and is qualified in its entirety by reference to the form of Non-Redemption Agreement filed herein as Exhibit 10.1 and incorporated herein by reference.

**Participants in the Solicitation**

The Company and its directors and executive officers and other persons may be deemed to be participants in the solicitation of proxies from the Company's stockholders in respect of the Extension. Information regarding the Company's directors and executive officers is available in its annual report on Form 10-K filed with the Securities and Exchange Commission (the "***SEC***"). Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests are contained in the Proxy Statement (defined below).

**No Offer or Solicitation** 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

**Additional Information** 

The Company has filed with the SEC definitive proxy statement for the Special Meeting (the "***Proxy Statement***") to consider and vote upon the Extension and other matters and, beginning on February 15, 2023, mailed the Proxy Statement and other relevant documents to its stockholders as of the January 31, 2023 record date for the Special Meeting. The Company's stockholders and other interested persons are advised to read the Proxy Statement and any other relevant documents that have been or will be filed with the SEC in connection with the Company's solicitation of proxies for the Special Meeting because these documents will contain important information about the Company, the Extension and related matters. Stockholders may also obtain a free copy of the Proxy Statement, as well as other relevant documents that have been or will be filed with the SEC, without charge, at the SEC's website located at www.sec.gov or by directing a request to Morrow Sodali LLC at (800) 662-5200 (toll free) or by email at FRXB@investor.morrowsodali.com.

**Item 9.01** **Financial Statements and Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(d)* *Exhibits* 

The following exhibit is filed herewith:

---

| | |
|:---|:---|
| **Exhibit No.** | **Description of Exhibits** |
| 10.1 | [Form of Non-Redemption Agreement](ea173876ex10-1_forest2.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: February 17, 2023

---

| | | |
|:---|:---|:---|
| **FOREST ROAD ACQUISITION CORP. II** | **FOREST ROAD ACQUISITION CORP. II** | **FOREST ROAD ACQUISITION CORP. II** |
| By: | /s/ Zachary Tarica | /s/ Zachary Tarica |
|  | Name: | Zachary Tarica |
|  | Title: | Chief Operating Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

**NON-REDEMPTION AGREEMENT AND ASSIGNMENT OF ECONOMIC INTEREST**

This Non-Redemption Agreement and Assignment of Economic Interest (this "<u>Agreement</u>") is entered as of _____, 2023 by and among Forest Road Acquisition Corp. II (the "<u>Company</u>"), Forest Road Acquisition Sponsor II LLC (the "<u>Sponsor</u>") and the undersigned investor ("<u>Investor</u>").

**RECITALS**

**WHEREAS**, the Sponsor currently holds shares of Class B common stock of the Company, which were initially purchased by the Sponsor in a private placement prior to the Company's initial public offering (the "<u>Founder Shares</u>");

**WHEREAS**, the Company has scheduled for March 3, 2023 a special meeting of stockholders (such scheduled meeting, including any duly approved adjournment thereof, the "<u>Meeting</u>") for the purpose of seeking stockholder approval of, among other things, an amendment to the Company's Amended and Restated Certificate of Incorporation (the "<u>Charter</u>") to extend the date by which the Company must consummate an initial business combination (the "<u>Initial Business Combination</u>") for nine additional months until December 12, 2023 (such proposed Charter amendment, as proposed to be considered and voted upon at the Meeting, the "<u>Extension Amendment</u>");

**WHEREAS**, the Charter provides that a stockholder of the Company may redeem its Class A common stock, par value $0.0001 per share, initially sold as part of the units in the Company's initial public offering (whether they were purchased in our initial public offering or thereafter in the open market) (the "<u>Public Shares</u>" and together with the Founder Shares, the "<u>Common Stock</u>") in connection with the Extension Amendment, on the terms set forth in the Charter ("<u>Redemption Rights</u>");

**WHEREAS**, subject to the terms and conditions of this Agreement, the Sponsor desires to transfer to Investor, and Investor desires to acquire from the Sponsor, that number of Founder Shares set forth opposite such Investor's name on <u>Exhibit A</u> (the "<u>Assigned Securities</u>"), to be transferred to Investor in connection with the Company's completion of its Initial Business Combination, and, prior to the transfer of the Assigned Securities to Investor, the Sponsor desires to assign the economic benefits of the Assigned Securities to Investor.

**NOW THEREFORE**, in consideration of the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Investor, the Sponsor, and the Company hereby agree as follows:

1. <u>Terms of Transfer</u>.

&nbsp;&nbsp;&nbsp;&nbsp;1.1. (a) Upon the terms and subject to the conditions of this
Agreement, the Sponsor agrees that if (a) as of 5:00 PM, New York time, on the date of the Meeting, Investor holds the Investor Shares
(as defined below), (b) Investor did not exercise its Redemption Rights with respect to such Investor Shares in connection with the Meeting,
and (c) the Extension Amendment is approved at the Meeting and is effected by the Company's filing with the Secretary of the State
of Delaware of an amendment to the Charter, then the Sponsor hereby agrees to (i) assign and transfer to Investor for no additional consideration
the Assigned Securities set forth on <u>Exhibit A</u> at such time as the conditions set forth in Section 1.2 below are satisfied and
(ii) assign to Investor the Economic Interest (as defined below) associated with the Assigned Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The term "<u>Investor Shares</u>" shall mean [______] Public Shares; *provided, however,* that if the number of Investor Shares is less than [______], the number of Assigned Securities<sup>1</sup> shall be reduced proportionately.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The Sponsor agrees to provide Investor with information stating (i) the number of Public Shares elected to be redeemed pursuant to the exercise of Redemption Rights in connection with the Meeting, (ii) the number of Public Shares that will remain outstanding after the Company has effectuated such redemptions, and (iii) the resultant calculation of the definitive number of Public Shares that constitute the Investor Shares for purposes of this Agreement, in each case no later than 9:00 a.m. New York time on the first business day following the date of the Meeting, which time shall be prior to the Company effectuating any redemptions made in connection with the Meeting.

&nbsp;&nbsp;&nbsp;&nbsp;1.2. The Sponsor and Investor hereby agree that the assignment
and transfer of the Assigned Securities shall be subject to the conditions that (i) the Initial Business Combination is consummated;
and (ii) Investor (or one or more of its permitted transferees (as described in the Letter Agreement (the " <u>Permitted Transferees</u> "))
executes a joinder to that certain Letter Agreement, dated March 9, 2021 (as it exists on the date hereof, the " <u>Letter Agreement</u> "),
by and among the Company, the Sponsor, officers and directors of the Company, and the other stockholders of the Company signatory thereto,
as described in Section 1.8 hereof.

Upon the satisfaction of the foregoing conditions, the Sponsor shall promptly assign and transfer the Assigned Securities to Investor (or its Permitted Transferees). The Sponsor covenants and agrees to facilitate such transfer to Investor (or its Permitted Transferees) in accordance with the foregoing.

&nbsp;&nbsp;&nbsp;&nbsp;1.3. <u>Adjustment to Share Amounts</u>. If at any time the number
of outstanding Founder Shares is increased or decreased by a consolidation, combination, subdivision or reclassification of the Common
Stock of the Company or other similar event (other than the conversion of Founder Shares to shares of Class A common stock in accordance
with the Company's Charter), then, as of the effective date of such consolidation, combination, subdivision, reclassification or
similar event, all share numbers referenced in this Agreement shall be adjusted in proportion to such increase or decrease in the Common
Stock.

&nbsp;&nbsp;&nbsp;&nbsp;1.4. <u>Merger or Reorganization, etc</u>. If there shall occur
any reorganization, recapitalization, reclassification, consolidation or merger involving the Company in which its Common Stock are converted
into or exchanged for securities, cash or other property, then, following any such reorganization, recapitalization, reclassification,
consolidation or merger, in lieu of common stock of the Company, the Sponsor shall transfer, with respect to each Founder Share to be
transferred hereunder, upon the Sponsor's receipt thereof, the kind and amount of securities, cash or other property into which
such Assigned Securities converted or exchanged.

<sup>1</sup> The number of Assigned Securities shall be an amount equal to 25% of the Investor Shares

&nbsp;&nbsp;&nbsp;&nbsp;1.5. <u>Forfeitures, Transfers, etc.</u> Investor shall not be
required to forfeit or transfer the Assigned Securities or any of its rights hereunder with respect to the Assigned Securities. Investor
acknowledges that, pursuant to the Amended and Restated Limited Liability Company Agreement of the Sponsor (as it exists on the date
hereof, the " <u>Sponsor LLC Agreement</u> "), prior to, or at the time of, the Initial Business Combination, the managing
member(s) of the Sponsor (the " <u>Managers</u> ") have the authority to cause the Sponsor to subject the Founder Shares to
earn-outs, forfeitures, transfers or other restrictions, or amend the terms under which the Founder Shares were issued or any restrictions
or other provisions relating to the Founder Shares set forth in the instruments establishing the same (including voting in favor of any
such amendment) or enter into any other arrangements with respect to the Founder Shares, and that the Managers are authorized to effectuate
such earn-outs, forfeitures, transfers, restrictions, amendments or arrangements, including arrangements relating to the relaxation or
early release of restrictions, in such amounts and pursuant to such terms as they determine in their sole and absolute discretion for
any reason. Sponsor acknowledges and agrees that any such earn-outs, forfeitures, transfers, restrictions, amendments or arrangements
shall apply only to the Founder Shares other than the Assigned Securities and the terms and conditions applicable to the Assigned Securities
and the Economic Interest shall not be changed as a result of any such earn-outs, forfeitures, transfers, restrictions, amendments or
arrangements.

&nbsp;&nbsp;&nbsp;&nbsp;1.6. <u>Delivery of Shares; Other Documents.</u> At the time of
the transfer of the Assigned Securities hereunder, the Sponsor shall deliver the Assigned Securities to Investor by transfer of book-entry
shares effected through the Company's transfer agent. The parties to this Agreement agree to execute, acknowledge and deliver such
further instruments and to do all such other acts, as may be necessary or appropriate to carry out the purposes and intent of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;1.7. <u>Assignment of Registration Rights</u>. Concurrent with
the transfer of the Assigned Securities to Investor under this Agreement, the Sponsor hereby assigns all of its rights, duties and obligations
to Investor with respect to the Assigned Securities under that certain Registration Rights Agreement, dated March 9, 2021 (as it exists
on the date of the Agreement, the " <u>Registration Rights Agreement</u> "), by and among the Company, the Sponsor, and the
other stockholders of the Company signatory thereto, and hereby represents and confirms to Investor that, upon Investor's receipt
of the Assigned Securities, (i) Investor shall be a "Holder" under the Registration Rights Agreement and (ii) the Assigned
Securities shall be "Registrable Securities" under the Registration Rights Agreement. The Sponsor shall provide written notice
to the Company of such assignment in accordance with the Registration Rights Agreement. Investor shall provide to the Company a written
agreement in accordance with the Registration Rights Agreement agreeing to be bound by the terms and provisions of the Registration Rights
Agreement as a "Holder" thereunder with respect to the Assigned Securities (upon acquisition thereof) as "Registrable
Securities" thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;1.8. <u>Joinder to Letter Agreement</u>. In connection with the
transfer of the Assigned Securities to Investor, Investor shall execute a joinder to the Letter Agreement in substantially the form attached
here to as <u>Exhibit B</u> (the " <u>Joinder</u> ") pursuant to which Investor shall agree with the Company to be bound solely
by Section 7 of the Letter Agreement solely with respect to the Assigned Securities and by the terms and provisions of the Registration
Rights Agreement as a "Holder" thereunder with respect to the Assigned Securities (upon acquisition thereof) as "Registrable
Securities" thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;1.9. <u>Termination</u>. This Agreement and each of the obligations
of the undersigned shall terminate on earlier of (a) the failure of the Company's stockholders to approve the Extension Amendment
at the Meeting, or the determination of the Company not to proceed to effect the Extension Amendment, (b) the fulfillment of all obligations
of parties hereto, (c) the liquidation or dissolution of the Company, and (d) the mutual written agreement of the parties hereto, (e)
if Investor exercises its Redemption Rights with respect to any Investor Shares in connection with the Meeting and such exercise is not
withdrawn by the commencement of the Meeting. Notwithstanding any provision in this Agreement to the contrary, the Sponsor's obligation
to transfer the Assigned Securities to Investor shall be conditioned on (i) the satisfaction of the conditions set forth in Section 1.2
and (ii) Investor not exercising its Redemption Rights with respect to such Investor Shares in connection with the Meeting.

2. <u>Assignment of Economic Interest</u>.

&nbsp;&nbsp;&nbsp;&nbsp;2.1. Upon satisfaction of the conditions set forth in Section
1.1, the Sponsor hereby assigns to Investor all of its economic right, title and interest in and to that number of Assigned Securities
set forth on <u>Exhibit A</u> (the " <u>Economic Interest</u> "), subject to adjustment as set forth in Section 1.3. The Economic
Interest represents the Sponsor's right to receive dividends and other distributions made by the Sponsor pursuant to the Sponsor
LLC Agreement allocated to that number of Assigned Securities set forth on <u>Exhibit A</u> represented by the Founder Shares held directly
by the Sponsor.

&nbsp;&nbsp;&nbsp;&nbsp;2.2. Investor acknowledges and agrees that it is not a member
of the Sponsor, it has no right to vote on matters of the Sponsor as a result of the Assigned Securities or Economic Interest, or to
vote with respect to any Assigned Securities, and it has no right to vote Assigned Securities prior to transfer of any such shares to
Investor pursuant to this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;2.3. Investor acknowledges and agrees that if it has a right pursuant
to its Economic Interest to receive any dividends or other distributions paid in Common Stock or other non-cash property that is subject
to the transfer restrictions and/or lockup period set forth in Section 7 of the Letter Agreement, the Sponsor shall transfer all of its
right, title and interest in such dividends or distributions concurrently with the transfer of the Assigned Securities to such Investor
pursuant to Section 1.

&nbsp;&nbsp;&nbsp;&nbsp;2.4. If the conditions to the transfer of the Assigned Securities
in Section 1 upon the consummation of an Initial Business Combination are not satisfied with respect to any Assigned Securities, then
Investor at such time shall automatically assign its Economic Interest in such Assigned Securities back to the Sponsor, for no consideration.

3. <u>Representations and Warranties of Investor</u>. Investor
represents and warrants to, and agrees with, the Sponsor that:

&nbsp;&nbsp;&nbsp;&nbsp;3.1. <u>No Government Recommendation or Approval</u>. Investor
understands that no federal or state agency has passed upon or made any recommendation or endorsement of the offering of the Assigned
Securities.

&nbsp;&nbsp;&nbsp;&nbsp;3.2. <u>Accredited Investor</u>. Investor is an "accredited
investor" as such term is defined in Rule 501(a) of Regulation D under the Securities Act of 1933, as amended (the " <u>Securities Act</u> "), and acknowledges that the sale contemplated hereby is being made in reliance, among other things, on a private placement
exemption to "accredited investors" under the Securities Act and similar exemptions under state law.

&nbsp;&nbsp;&nbsp;&nbsp;3.3. <u>Intent</u>. Investor is acquiring the Assigned
Securities solely for investment purposes, for such Investor's own account (and/or for the account or benefit of its members or
affiliates, as permitted), and not with a view to the distribution thereof in violation of the Securities Act and Investor has no present
arrangement to sell Assigned Securities to or through any person or entity except as may be permitted hereunder or contemplated by the
Letter Agreement and/or the Registration Rights Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;3.4. <u>Restrictions on Transfer; Trust Account; Redemption Rights</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4.1. Investor acknowledges and agrees that, prior to their transfer
hereunder, the Assigned Securities are, and following any transfer to Investor may continue to be, subject to the transfer restrictions
and certain other restrictions as set forth in paragraph 7 of the Letter Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4.2. Investor acknowledges and agrees that the Assigned Securities
are not entitled to, and have no right, interest or claim of any kind in or to, any monies held in the trust account into which the proceeds
of the Company's initial public offering were deposited (the " <u>Trust Account</u> ") or distributed as a result of
any liquidation of the Trust Account. Notwithstanding anything herein to the contrary and subject to the provisions of Section 3.4.3
below, Investor hereby waives any and all right, title, interest or claim of any kind (" <u>Claim</u> ") in or to any distribution
of or from the Trust Account except with respect to Public Shares (other than the Investor Shares) and hereby agrees not to seek recourse,
reimbursement, payment or satisfaction for any Claim against the Trust Account except with respect to Public Shares (other than the Investor
Shares).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4.3. Investor waives any right that it may have to elect to have
the Company redeem any Investor Shares in connection with the Extension Amendment, agrees not to redeem or otherwise exercise any right
to redeem the Investor Shares in connection with the Extension Amendment, and agrees to reverse and revoke any prior redemption elections
made with respect to the Investor Shares in connection with the Extension Amendment. For the avoidance of doubt, nothing in this Agreement
is intended to restrict or prohibit Investor's ability, in each case in its discretion, to (i) redeem any Public Shares (other
than the Investor Shares in connection with the Extension Amendment) or (ii) sell or otherwise dispose of any Public Shares (other than
the Investor Shares prior to the date of the Meeting).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4.4. Investor acknowledges and understands the Assigned Securities
are being offered in a transaction not involving a public offering in the United States within the meaning of the Securities Act and
have not been registered under the Securities Act and, if in the future Investor decides to offer, resell, pledge or otherwise transfer
Assigned Securities, such Assigned Securities may be offered, resold, pledged or otherwise transferred only (A) pursuant to an effective
registration statement filed under the Securities Act, (B) pursuant to an exemption from registration under Rule 144 promulgated
under the Securities Act, if available, or (C) pursuant to any other available exemption from the registration requirements of the
Securities Act, and in each case in accordance with any applicable securities laws of any state or any other jurisdiction. Investor
agrees that, if any transfer of the Assigned Securities or any interest therein is proposed to be made (other than pursuant to an effective
registration statement or Rule 144 under the Securities Act), as a condition precedent to any such transfer, Investor may be required
to deliver to the Company an opinion of counsel satisfactory to the Company that registration is not required with respect to the Assigned
Securities to be transferred. Absent registration or another available exemption from registration, Investor agrees it will not transfer
the Assigned Securities.

&nbsp;&nbsp;&nbsp;&nbsp;3.5. <u>Voting</u>. Investor agrees that it will and will cause
its controlled affiliates to vote (or cause to be voted) or execute and deliver a written consent (or cause a written consent to be executed
and delivered) all of the Common Stock owned, as of the applicable record date, by any of them at the Meeting in favor of the Extension
Amendment and cause all such shares to be counted as present at the Meeting for purposes of establishing a quorum.

&nbsp;&nbsp;&nbsp;&nbsp;3.6. <u>Sophisticated Investor</u>. Investor is sophisticated
in financial matters and able to evaluate the risks and benefits of the investment in the Assigned Securities.

&nbsp;&nbsp;&nbsp;&nbsp;3.7. <u>Risk of Loss</u>. Investor is aware that an investment
in the Assigned Securities is highly speculative and subject to substantial risks. Investor is cognizant of and understands the risks
related to the acquisition of the Assigned Securities, including those restrictions described or provided for in this Agreement, the
Sponsor LLC Agreement and the Letter Agreement pertaining to transferability. Investor is able to bear the economic risk of its
investment in the Assigned Securities for an indefinite period of time and able to sustain a complete loss of such investment.

&nbsp;&nbsp;&nbsp;&nbsp;3.8. <u>Independent Investigation</u>. Investor has
relied upon an independent investigation of the Company and has not relied upon any information or representations made by any third
parties or upon any oral or written representations or assurances, express or implied, from the Sponsor or any representatives or agents
of the Sponsor, other than as set forth in this Agreement. Investor is familiar with the business, operations and financial condition
of the Company and has had an opportunity to ask questions of, and receive answers from the Company's management concerning the
Company and the terms and conditions of the proposed sale of the Assigned Securities and has had full access to such other information
concerning the Company as Investor has requested. Investor confirms that all documents that it has requested have been made available
and that Investor has been supplied with all of the additional information concerning this investment which Investor has requested.

&nbsp;&nbsp;&nbsp;&nbsp;3.9. <u>Organization and Authority</u>. If an entity,
Investor is duly organized and existing under the laws of the jurisdiction in which it was organized and it possesses all requisite power
and authority to acquire the Assigned Securities, enter into this Agreement and perform all the obligations required to be performed
by Investor hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;3.10. <u>Non-U.S. Investor</u>. If Investor is not a United States
person (as defined by Section 7701(a)(30) of the U.S. Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder
(collectively, the " <u>Code</u> ")), Investor hereby represents that it has satisfied itself as to the full observance of
the laws of its jurisdiction in connection with any invitation to subscribe for the Assigned Securities or any use of this Agreement,
including (i) the legal requirements within its jurisdiction for the acquisition of the Assigned Securities, (ii) any foreign exchange
restrictions applicable to such acquisition, (iii) any governmental or other consents that may need to be obtained, and (iv) the income
tax and other tax consequences, if any, that may be relevant to the acquisition, holding, redemption, sale, or transfer of the Assigned
Securities. Investor's subscription and payment for and continued beneficial ownership of the Assigned Securities will not violate
any applicable securities or other laws of Investor's jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;3.11. <u>Authority</u>. This Agreement has been validly authorized,
executed and delivered by Investor and (assuming due authorization, execution and delivery by the Sponsor and the Company) is a valid
and binding agreement of Investor enforceable against Investor in accordance with its terms, except as such enforceability may be limited
by applicable bankruptcy, insolvency, fraudulent conveyance, moratorium, reorganization, or similar laws relating to, or affecting generally
the enforcement of, creditors' rights and remedies or by equitable principles of general application and except as enforcement
of rights to indemnity and contribution may be limited by federal and state securities laws or principles of public policy.

&nbsp;&nbsp;&nbsp;&nbsp;3.12. <u>No Conflicts</u>. The execution, delivery and performance
of this Agreement and the consummation by Investor of the transactions contemplated hereby do not violate, conflict with or constitute
a default under (i) Investor's organizational documents, (ii) any agreement or instrument to which Investor is a party or
(iii) any law, statute, rule or regulation to which Investor is subject, or any order, judgment or decree to which Investor is subject,
in the case of clauses (ii) and (iii), that would reasonably be expected to prevent Investor from fulfilling its obligations under this
Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;3.13. <u>No Advice from Sponsor</u>. Investor has had the opportunity
to review this Agreement and the transactions contemplated by this Agreement and the Letter Agreement with Investor's own legal
counsel and investment and tax advisors. Except for any statements or representations of the Sponsor explicitly made in this
Agreement, Investor is relying solely on such counsel and advisors and not on any statements or representations, express or implied,
of the Sponsor or any of its representatives or agents for any reason whatsoever, including without limitation for legal, tax or investment
advice, with respect to this investment, the Sponsor, the Company, the Assigned Securities, the transactions contemplated by this Agreement
or the securities laws of any jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;3.14. <u>Reliance on Representations and Warranties</u>. Investor understands that the Assigned Securities
 are being offered and sold to Investor in reliance on exemptions from the registration requirements under the Securities Act, and
 analogous provisions in the laws and regulations of various states, and that the Sponsor is relying upon the truth and accuracy of
 the representations, warranties, agreements, acknowledgments and understandings of Investor set forth in this Agreement in order to
 determine the applicability of such provisions.

&nbsp;&nbsp;&nbsp;&nbsp;3.15. <u>No General Solicitation</u>. Assuming the accuracy of the Sponsor's representations and
 warranties in Section 4.5, Investor is not subscribing for Assigned Securities as a result of or subsequent to any general
 solicitation or general advertising within the meaning of Regulation D under the Securities Act, including but not limited to any
 advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or broadcast over
 television or radio or any seminar or meeting whose attendees have been invited by any general solicitation or general
 advertising.

&nbsp;&nbsp;&nbsp;&nbsp;3.16. <u>Brokers</u>. No broker, finder or intermediary has
been paid or is entitled to a fee or commission from or by Investor in connection with the acquisition of the Assigned Securities nor
is Investor entitled to or will accept any such fee or commission.

4. <u>Representations and Warranties of Sponsor</u>. The Sponsor represents and warrants to, and agrees with, the Investor that:

&nbsp;&nbsp;&nbsp;&nbsp;4.1. <u>Power and Authority</u>. The Sponsor is a limited
liability company duly formed and validly existing and in good standing as a limited liability company under the laws of the State of
Delaware and possesses all requisite limited liability company power and authority to enter into this Agreement and to perform all of
the obligations required to be performed by the Sponsor hereunder, including the assignment, sale and transfer the Assigned Securities.

&nbsp;&nbsp;&nbsp;&nbsp;4.2. <u>Authority</u>. All corporate action on the part of the
Sponsor and its officers, directors and members necessary for the authorization, execution and delivery of this Agreement and the performance
of all obligations of the Sponsor required pursuant hereto has been taken. This Agreement has been duly executed and delivered by the
Sponsor and (assuming due authorization, execution and delivery by Investor) constitutes the Sponsor's legal, valid and binding
obligation, enforceable against the Sponsor in accordance with its terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, fraudulent conveyance, moratorium, reorganization, or similar laws relating to, or affecting generally the enforcement
of, creditors' rights and remedies or by equitable principles of general application and except as enforcement of rights to indemnity
and contribution may be limited by federal and state securities laws or principles of public policy.

&nbsp;&nbsp;&nbsp;&nbsp;4.3. <u>Title to Securities</u>. The Sponsor is the record and
beneficial owner of, and has good and marketable title to, the Assigned Securities and will, immediately prior to the transfer of the
Assigned Securities to Investor, be the record and beneficial owner of the Assigned Securities, in each case, free and clear of all liens,
pledges, security interests, charges, claims, encumbrances, agreements, options, voting trusts, proxies and other arrangements or restrictions
of any kind (other than transfer restrictions and other terms and conditions that apply to the Founder Shares generally and applicable
securities laws). The Assigned Securities to be transferred, when transferred to Investor as provided herein, will be free and clear
of all liens, pledges, security interests, charges, claims, encumbrances, agreements, options, voting trusts, proxies and other
arrangements or restrictions of any kind (other than transfer restrictions and other terms and conditions that apply to the Founder Shares
generally, under the Letter Agreement and applicable securities laws). The Assigned Securities are duly authorized, fully paid, and non-assessable.

&nbsp;&nbsp;&nbsp;&nbsp;4.4. <u>No Conflicts</u>. The execution, delivery and performance
of this Agreement and the consummation by the Sponsor of the transactions contemplated hereby do not violate, conflict with or constitute
a default under (i) the certificate of formation or the Sponsor LLC Agreement, (ii) any agreement or instrument to which the Sponsor
is a party or by which it is bound (including the Letter Agreement and the Sponsor LLC Agreement) or (iii) any law, statute, rule or
regulation to which the Sponsor is subject or any order, judgment or decree to which the Sponsor is subject. The Sponsor is not required
under federal, state or local law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration
with, any court or governmental agency or self-regulatory entity in order for it to perform any of its obligations under this Agreement
or transfer the Assigned Securities in accordance with the terms hereof.

&nbsp;&nbsp;&nbsp;&nbsp;4.5. <u>No General Solicitation</u>. The Sponsor has not offered the Assigned Securities by means of any
 general solicitation or general advertising within the meaning of Regulation D of the Securities Act, including but not limited to
 any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or broadcast over
 television or radio or any seminar or meeting whose attendees have been invited by any general solicitation or general
 advertising.

&nbsp;&nbsp;&nbsp;&nbsp;4.6. <u>Brokers</u>. No broker, finder or intermediary has
been paid or is entitled to a fee or commission from or by the Sponsor in connection with the sale of the Assigned Securities nor is
the Sponsor entitled to or will accept any such fee or commission.

&nbsp;&nbsp;&nbsp;&nbsp;4.7. <u>Transfer Restrictions</u>. Until termination of this Agreement,
the Sponsor shall not transfer any of the Assigned Securities or any economic benefit of the Assigned Securities other than any transfer
pursuant to the Sponsor LLC Agreement in connection with an Initial Business Combination.

&nbsp;&nbsp;&nbsp;&nbsp;4.8. <u>Reliance on Representations and Warranties</u>. The Sponsor understands and acknowledges that
 Investor is relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings
 of the Sponsor set forth in this Agreement.

5. <u>Trust Account</u>. Until the earlier of (a) the consummation
of the Company's Initial Business Combination; (b) the liquidation of the Trust Account; and (c) 24 months from consummation of
the Company's initial public offering or such later time as the stockholders of the Company may approve in accordance with the
Charter, the Company will maintain the investment of funds held in the Trust Account in interest-bearing United States government securities
within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, having a maturity of 185 days or less,
or in money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 promulgated under the Investment
Company Act of 1940, as amended, which invest only in direct U.S. government treasury obligations, or maintain such funds in cash in
an interest-bearing demand deposit account at a bank. The Company further confirms that, in order to mitigate the current uncertainty
surrounding the implementation of the Inflation Reduction Act of 2022, funds held in the Trust Account, including any interest thereon,
will not be used to pay for any excise tax liabilities with respect to any future redemptions prior to or in connection with the Extension
Amendment, an Initial Business Combination or liquidation of the Company.

6. <u>Governing Law; Jurisdiction; Waiver of Jury Trial</u>. This Agreement shall be governed by and construed and enforced in accordance
with the laws of the State of New York, without giving effect to its principles or rules of conflict of laws to the extent such principles
or rules would require or permit the application of the laws of another jurisdiction. The parties hereto hereby waive any right to a jury
trial in connection with any litigation pursuant to this Agreement and the transactions contemplated hereby. With respect to any suit,
action or proceeding relating to the transactions contemplated hereby, the undersigned irrevocably submit to the jurisdiction of the United
States District Court or, if such court does not have jurisdiction, the New York state courts located in the Borough of Manhattan, State
of New York, which submission shall be exclusive.

7. <u>Assignment; Entire Agreement; Amendment</u>.

&nbsp;&nbsp;&nbsp;&nbsp;7.1. <u>Assignment</u>. Any assignment of this Agreement or
any right, remedy, obligation or liability arising hereunder by either the Sponsor or Investor shall require the prior written consent
of the other party; *provided,* that no such consent shall be required for any such assignment to one or more affiliates of the
assigning party.

&nbsp;&nbsp;&nbsp;&nbsp;7.2. <u>Entire Agreement</u>. This Agreement sets forth the entire
agreement and understanding between the parties as to the subject matter thereof and merges and supersedes all prior discussions, agreements
and understandings of any and every nature among them.

&nbsp;&nbsp;&nbsp;&nbsp;7.3. <u>Amendment</u>. Except as expressly provided in this Agreement,
neither this Agreement nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument signed
by the party against whom enforcement of any such amendment, waiver, discharge or termination is sought.

&nbsp;&nbsp;&nbsp;&nbsp;7.4. <u>Binding upon Successors</u>. This Agreement shall be binding
upon and inure to the benefit of the parties hereto and to their respective heirs, legal representatives, successors and permitted assigns.

8. <u>Notices</u>. Unless otherwise provided herein, any notice or other communication to a party hereunder shall be sufficiently given
if in writing and personally delivered or sent by facsimile or other electronic transmission with copy sent in another manner herein provided
or sent by courier (which for all purposes of this Agreement shall include Federal Express or another recognized overnight courier) or
mailed to said party by certified mail, return receipt requested, at its address provided for herein or such other address as either may
designate for itself in such notice to the other. Communications shall be deemed to have been received when delivered personally,
on the scheduled arrival date when sent by next day or 2nd-day courier service, or if sent by facsimile upon receipt of confirmation of
transmittal or, if sent by mail, then three days after deposit in the mail. If given by electronic transmission, such notice shall be
deemed to be delivered (a) if by electronic mail, when directed to an electronic mail address at which the party has provided to
receive notice; and (b) if by any other form of electronic transmission, when directed to such party.

9. <u>Counterparts</u>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. Counterparts may be delivered via facsimile, electronic
mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic
Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered
shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

10. <u>Survival; Severability</u> 

&nbsp;&nbsp;&nbsp;&nbsp;10.1. <u>Survival</u>. The representations, warranties, covenants
and agreements of the parties hereto shall survive the closing of the transactions contemplated hereby.

&nbsp;&nbsp;&nbsp;&nbsp;10.2. <u>Severability</u>. In the event that any provision of this
Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue
in full force and effect without said provision; provided that no such severability shall be effective if it materially changes the economic
benefit of this Agreement to any party.

11. <u>Headings</u> *.* The titles and subtitles used in
this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.

12. <u>Disclosure; Waiver</u>. As soon as practicable, but in
no event later than one business day, after execution of this Agreement, the Company will file a Current Report on Form 8-K under the
Securities Exchange Act of 1934, as amended (the " <u>Exchange Act</u> ") (the " <u>Form 8-K</u> "), disclosing,
to the extent not previously disclosed, (a) the material terms of this Agreement and (b) any other material non-public information that
the Sponsor, the Company, or any person acting on behalf of either has provided to Investor at any time prior to the filing of the Form
8-K. The parties to this Agreement shall cooperate with one another to assure that such disclosure is accurate. The Company agrees that
the name of the investor shall not be included in any public disclosures related to this Agreement unless required by applicable law,
regulation or stock exchange rule . Investor (i) acknowledges that the Sponsor
may possess or have access to material non-public information which has not been communicated to the Investor; (ii) hereby waives any
and all claims, whether at law, in equity or otherwise, that he, she, or it may now have or may hereafter acquire, whether presently
known or unknown, against the Sponsor or any of the Company's officers, directors, employees, agents, affiliates, subsidiaries,
successors or assigns relating to any failure to disclose any non-public information in connection with the transaction contemplated
by this Agreement, including any potential business combination involving the Company, including without limitation, any claims arising
under Rule 10-b(5) of the Exchange Act; and (iii) is aware that the Sponsor is relying on the truth of the representations set forth
in Section 3 of this Agreement and the foregoing acknowledgement and waiver in this Section 12, in connection with the transactions contemplated
by this Agreement. The Sponsor and the Company acknowledge and represent that u pon the filing of the Form 8-K, Investor shall
not be in possession of any material non-public information received from the Sponsor, the Company, or any person acting on behalf of
either.

13. <u>Independent Nature of Rights and Obligations</u>. Nothing contained herein, and no action taken by any party pursuant hereto, shall
be deemed to constitute Investor and the Sponsor as, and the Sponsor acknowledges that Investor and the Sponsor do not so constitute,
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that Investor and the Sponsor are
in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by this Agreement or any
matters, and the Sponsor acknowledges that Investor and the Sponsor are not acting in concert or as a group, and the Sponsor shall not
assert any such claim, with respect to such obligations or the transactions contemplated by this Agreement.

14. <u>Most Favored Nation</u>. In the event the Sponsor has
entered or enters into one or more other non-redemption agreements before or after the execution of this Agreement in connection with
the Meeting (each, an " <u>Other Agreement</u> " and, the Company stockholder party thereto, an " <u>Other Investor</u> "),
the Sponsor represents and covenants that the terms of such Other Agreement are not or will not be materially more favorable to such
Other Investor than the terms of this Agreement are in respect of Investor. In the event that any Other Investor is afforded any materially
more favorable terms than Investor, the Sponsor shall promptly inform Investor of such more favorable terms in writing, and Investor
shall have the right to elect to have such more favorable terms included herein, in which case the parties hereto shall promptly amend
this Agreement to effect the same.

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

---

| | |
|:---|:---|
| **INVESTOR** | **INVESTOR** |
| By: |  |
|  | Name: |
|  | Title: |

---

*[Signature Page to Non-Redemption Agreement]*

 

---

| | |
|:---|:---|
| **SPONSOR:** | **SPONSOR:** |
| Forest Road Acquisition Sponsor II LLC | Forest Road Acquisition Sponsor II LLC |
| By: |  |
|  | Name: |
|  | Title: |
| **COMPANY:** | **COMPANY:** |
| FOREST ROAD ACQUISITION CORP. II | FOREST ROAD ACQUISITION CORP. II |
| By: |  |
|  | Name: |
|  | Title: |

---

*[Signature Page to Non-Redemption Agreement]*

<u>Exhibit A</u>

---

| | | |
|:---|:---|:---|
| **Investor** | **Assigned Securities / Economic Interest Assigned** | **Number of Public Shares to be Held as Investor Shares** |
| <br> [_________________________]<br> [_____________________]<br>EIN/SSN: [___________________] | <br> [______]<br>Class B Common Stock<br>| <br> [______]<br>Class A Common Stock<br>|

---

EXHIBIT B

FORM OF JOINDER

TO

LETTER AGREEMENT

AND

REGISTRATION RIGHTS AGREEMENT

______, 20_

Reference is made to that certain Non-Redemption Agreement and Assignment of Economic Interest, dated as of , 2023 (the "<u>Agreement</u>"), by and among ______________________ ("<u>Investor</u>"), Forest Road Acquisition Corp. II (the "<u>Company</u>") and Forest Road Acquisition Sponsor II LLC (the "<u>Sponsor</u>"), pursuant to which Investor shall be entitled to acquire securities of the Company from the Sponsor. Capitalized terms used and not otherwise defined herein shall have the meanings given to such terms in the Agreement.

By executing this joinder, Investor hereby agrees, as of the date first set forth above, that Investor (i) shall become a party to that certain Letter Agreement, dated March 9, 2021 (as it exists on the date of the Agreement, the "<u>Letter Agreement</u>"), by and among the Company, the Sponsor, officers and directors of the Company, and the other stockholders of the Company signatory thereto, solely with respect to Section 7 of the Letter Agreement, and shall be bound by, and shall be subject to the restrictions set forth under, the terms and provisions of such section of the Letter Agreement as an Insider (as defined therein) solely with respect to its Assigned Securities; and (ii) shall become a party to that certain Registration Rights Agreement, dated March 9, 2021 (as it exists on the date of the Agreement, the "<u>Registration Rights Agreement</u>"), by and among the Company, the Sponsor, and the other stockholders of the Company signatory thereto, and shall be bound by the terms and provisions of the Registration Rights Agreement as an Investor (as defined therein) and entitled to the rights of an Investor under the Registration Rights Agreement and the Assigned Securities (together with any other equity security of the Company issued or issuable with respect to any such Assigned Securities by way of a share dividend or share subdivision or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization) shall be "Registrable Securities" thereunder.

For the purposes of clarity, it is expressly understood and agreed that each provision contained herein, in the Letter Agreement (to the extent applicable to Investor) and the Registration Rights Agreement is between the Company and Investor, solely, and not between and among Investor and the other stockholders of the Company signatory thereto.

This joinder may be executed in two or more counterparts, and by facsimile, all of which shall be deemed an original and all of which together shall constitute one instrument.

---

| |
|:---|
| **INVESTOR** |
| By: |
| Name: |
| Title: |

---

---

| | |
|:---|:---|
| **<u>ACKNOWLEDGED AND AGREED:</u>** | **<u>ACKNOWLEDGED AND AGREED:</u>** |
| FOREST ROAD ACQUISITION CORP. II | FOREST ROAD ACQUISITION CORP. II |
| By: |  |
|  | Name: |
|  | Title: |

---